Ceftin and Dexilant drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ceftin (cefuroxime axetil) and Dexilant (dexlansoprazole). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Ceftin and Dexilant. It is created by eHealthMe based on reports of 51 people who take the same drugs from the FDA, and is updated regularly.

What is Ceftin?

Ceftin has active ingredients of cefuroxime axetil. It is often used in sinusitis. eHealthMe is studying from 4,333 Ceftin users. Check the latest studies of Ceftin.

What is Dexilant?

Dexilant has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 57,103 Dexilant users. Check the latest studies of Dexilant.



On Jul, 12, 2026

51 people who take Ceftin and Dexilant together, and have interactions are studied.

Ceftin and Dexilant drug interactions.

What are the common drug interactions of Ceftin and Dexilant, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Impaired gastric emptying
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Muscle spasms (muscle contraction)
  8. Renal injury (kidney injury)
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Haematuria (presence of blood in urine)
  4. Nephrolithiasis (calculi in the kidneys)
  5. Nephropathy (damage to or disease of a kidney)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Dyspnoea (difficult or laboured respiration)
  9. Erythema (redness of the skin)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Ceftin and Dexilant, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Renal injury (kidney injury)
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Impaired gastric emptying
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Dysuria (painful or difficult urination)
  8. Haematuria (presence of blood in urine)
  9. Nephrolithiasis (calculi in the kidneys)
  10. Nephropathy (damage to or disease of a kidney)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Dyspnoea (difficult or laboured respiration)
  4. Pyrexia (fever)
  5. Hepatic steatosis (fatty liver disease)
  6. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  7. Renal disorder (kidney disease)
  8. Abdominal discomfort
  9. Abdominal pain
  10. Acute respiratory failure

What are the existing conditions these people have? *

  1. Pain: 22 people, 43.14%
  2. Infection: 10 people, 19.61%
  3. High Blood Cholesterol: 10 people, 19.61%
  4. High Blood Pressure: 10 people, 19.61%
  5. Depression: 9 people, 17.65%
  6. Cough: 8 people, 15.69%
  7. Multiple Allergies (allergy to multiple agents): 7 people, 13.73%
  8. Stress And Anxiety: 7 people, 13.73%
  9. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 13.73%
  10. Nausea (feeling of having an urge to vomit): 7 people, 13.73%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftin and Dexilant?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ceftin and Dexilant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ceftin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dexilant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dexilant and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cefuroxime axetil and dexlansoprazole (the active ingredients of Ceftin and Dexilant, respectively), and Ceftin and Dexilant (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: